医療関係者でない場合はコーポレートサイトへアクセスしてください
会員登録を完了しました
GSKproのご登録ありがとうございます。完了メールをご登録アドレス宛にお送りしております。
引き続き、GSKproの会員限定コンテンツをお楽しみください。
Event Registration successful
You now have sucesfully register for the event and you can also access the latest updates, events and resources.
In case you would like to receive SMS-reminders for the event you have registered, please scroll down to provide your mobile number.
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Event registration completed - pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We'll send you and email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.
Account activated - pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy the public content on our website
Event Account activated - pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy the public content on our website
In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.
厚生労働省研究班によって策定された痙攣性発声障害の診断基準では、診断時の必須条件として５つの項目を挙げています。また、内転型と外転型のそれぞれについて４つの主要症状を示すとともに、参考となる所見や発声時の所見、治療反応性、鑑別疾患についても記載しています。
詳しくは下記の診断基準・重症度分類をご参照ください。
痙攣性発声障害の治療選択肢として、内喉頭筋に対するボツリヌス毒素製剤の注射（ボツリヌス療法）、および手術（甲状軟骨形成術Ⅱ型、甲状披裂筋切除術など）が挙げられます。
音声治療（音声訓練）は、合併した発声障害の軽減には有用ですが、音声治療によって痙攣性発声障害の主症状が消失することはありません。そのため、音声治療の著効例では痙攣性発声障害を否定することができます。
